DROPERIDOL (C005B-048198)

Biochem/physiol Actions

D₁, D₂ dopamine receptor antagonist; butyrophenone antipsychotic and anti-emetic.

Droperidol is a potent antagonist of dopamine subtype 2 receptor. It is an antipsychotic, which is used to treat acute behavioral anomalies. It helps to manage postoperative nausea and vomiting.

Features and Benefits

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

UPC:

51332508

Condition:

New

Weight:

1.00 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

GR

MPN:

D1414-1G

CAS:

548-73-2